Last reviewed · How we verify

NCT06053606

The Impact of Expandable Cryoballoon on Autonomic Control of the Heart

Recruiting now NA Last updated 24 July 2025
What this trial tests

NA trial testing cryoablation of atrial fibrillation using only 28 mm size balloon in Paroxysmal Atrial Fibrillation in 100 participants. Currently enrolling.

Timeline
10 May 2024
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorWroclaw Medical University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date10 May 2024
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Wroclaw Medical University

Who can join

Adults 18 to 79, any sex, with Paroxysmal Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Approximately 40% of patients following cryoballoon ablation show signs of parasympathetic denervation. The presence of such effect is related to better outcomes in terms of clinical efficacy (freedom from atrial fibrillation). It could be hypothesized that larger sized balloon (POLARxFIT system) because of more antral position within the left atrium (and hence smaller distance from ganglionated plexi) might enhance this beneficial modulation of the autonomic system of the heart. This study intends to compare the effects of cryoablation employing expandable balloon (POLARxFIT) vs. standard balloon (POLARx) on autonomic system of the heart.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Paroxysmal Atrial Fibrillation

Currently open trials in the same condition.

Other Wroclaw Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06053606.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing